These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19945406)

  • 1. Prevention of steatosis by hepatic JNK1.
    Sabio G; Cavanagh-Kyros J; Ko HJ; Jung DY; Gray S; Jun JY; Barrett T; Mora A; Kim JK; Davis RJ
    Cell Metab; 2009 Dec; 10(6):491-8. PubMed ID: 19945406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.
    Kodama Y; Kisseleva T; Iwaisako K; Miura K; Taura K; De Minicis S; Osterreicher CH; Schnabl B; Seki E; Brenner DA
    Gastroenterology; 2009 Oct; 137(4):1467-1477.e5. PubMed ID: 19549522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance.
    Zhang QY; Zhao LP; Tian XX; Yan CH; Li Y; Liu YX; Wang PX; Zhang XJ; Han YL
    Hepatology; 2017 Sep; 66(3):834-854. PubMed ID: 28508477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance.
    Sabio G; Das M; Mora A; Zhang Z; Jun JY; Ko HJ; Barrett T; Kim JK; Davis RJ
    Science; 2008 Dec; 322(5907):1539-43. PubMed ID: 19056984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.
    Sabio G; Davis RJ
    Trends Biochem Sci; 2010 Sep; 35(9):490-6. PubMed ID: 20452774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism.
    Belgardt BF; Mauer J; Wunderlich FT; Ernst MB; Pal M; Spohn G; Brönneke HS; Brodesser S; Hampel B; Schauss AC; Brüning JC
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6028-33. PubMed ID: 20231445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice.
    Yu XX; Murray SF; Watts L; Booten SL; Tokorcheck J; Monia BP; Bhanot S
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E436-45. PubMed ID: 18523126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JNK1 ablation in mice confers long-term metabolic protection from diet-induced obesity at the cost of moderate skin oxidative damage.
    Becattini B; Zani F; Breasson L; Sardi C; D'Agostino VG; Choo MK; Provenzani A; Park JM; Solinas G
    FASEB J; 2016 Sep; 30(9):3124-32. PubMed ID: 27230858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance.
    Sabio G; Kennedy NJ; Cavanagh-Kyros J; Jung DY; Ko HJ; Ong H; Barrett T; Kim JK; Davis RJ
    Mol Cell Biol; 2010 Jan; 30(1):106-15. PubMed ID: 19841069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity.
    Gao Z; Zhang J; Kheterpal I; Kennedy N; Davis RJ; Ye J
    J Biol Chem; 2011 Jun; 286(25):22227-34. PubMed ID: 21540183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid.
    Yang YM; Seo SY; Kim TH; Kim SG
    Hepatology; 2012 Dec; 56(6):2209-20. PubMed ID: 22807119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance.
    Singh R; Wang Y; Xiang Y; Tanaka KE; Gaarde WA; Czaja MJ
    Hepatology; 2009 Jan; 49(1):87-96. PubMed ID: 19053047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
    Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
    J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the hypothalamic-pituitary-thyroid axis in metabolic regulation by JNK1.
    Sabio G; Cavanagh-Kyros J; Barrett T; Jung DY; Ko HJ; Ong H; Morel C; Mora A; Reilly J; Kim JK; Davis RJ
    Genes Dev; 2010 Feb; 24(3):256-64. PubMed ID: 20080940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease.
    Valenti L; Mendoza RM; Rametta R; Maggioni M; Kitajewski C; Shawber CJ; Pajvani UB
    Diabetes; 2013 Dec; 62(12):4052-62. PubMed ID: 23990360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Mc1 improves liver steatosis and insulin resistance by attenuating ER stress.
    Roh E; Hwang HJ; Kim JW; Hong SH; Kim JA; Lee YB; Choi KM; Baik SH; Yoo HJ
    J Ethnopharmacol; 2020 Sep; 259():112927. PubMed ID: 32387461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha.
    Kosters A; White DD; Sun H; Thevananther S; Karpen SJ
    J Hepatol; 2009 Nov; 51(5):898-908. PubMed ID: 19767119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.
    Samuel VT; Liu ZX; Qu X; Elder BD; Bilz S; Befroy D; Romanelli AJ; Shulman GI
    J Biol Chem; 2004 Jul; 279(31):32345-53. PubMed ID: 15166226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice.
    Thomas A; Belaidi E; Aron-Wisnewsky J; van der Zon GC; Levy P; Clement K; Pepin JL; Godin-Ribuot D; Guigas B
    Sci Rep; 2016 Apr; 6():24618. PubMed ID: 27094951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent.
    Gan LT; Van Rooyen DM; Koina ME; McCuskey RS; Teoh NC; Farrell GC
    J Hepatol; 2014 Dec; 61(6):1376-84. PubMed ID: 25064435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.